Skip to main content
Fig. 2 | Trials

Fig. 2

From: Randomised open label exploratory, safety and tolerability study with calmangafodipir in patients treated with the 12-h regimen of N-acetylcysteine for paracetamol overdose—the PP100–01 for Overdose of Paracetamol (POP) trial: study protocol for a randomised controlled trial

Fig. 2

The paracetamol treatment nomogram used in the United Kingdom. After a single acute overdose, the patient’s plasma/serum paracetamol concentration is plotted on the graph using the time from overdose to blood draw. If above the treatment line the patient receives acetylcysteine treatment at a dose of 300 mg/kg body weight

Back to article page

Trials

ISSN: 1745-6215